The intrinsic lymphatic contractile activity is necessary for proper lymph transport.Mesenteric lymphatic vessels from high-fructose diet-induced metabolic syndrome (MetSyn) rats exhibited impairments in its intrinsic phasic contractile activity; however, the molecular mechanisms responsible for the weaker lymphatic pumping activity in MetSyn conditions are unknown. Several metabolic disease models have shown that dysregulation of sarcoplasmic reticulum Ca 2+ ATPase (SERCA) pump is one of the key determinants of the phenotypes seen in various muscle tissues. Hence, we hypothesized that a decrease in SERCA pump expression and/or activity in lymphatic muscle influences the diminished lymphatic vessel contractions in MetSyn animals. Results demonstrated that SERCA inhibitor, thapsigargin, significantly reduced lymphatic phasic contractile frequency and amplitude in control vessels, whereas, the reduced MetSyn lymphatic contractile activity was not further diminished by thapsigargin. While SERCA2a expression was significantly decreased in MetSyn lymphatic vessels, myosin light chain 20, MLC20 phosphorylation was increased in these vessels. Additionally, insulin resistant lymphatic muscle cells exhibited elevated intracellular calcium and decreased SERCA2a expression and activity. The SERCA activator, CDN 1163 increased phasic contractile frequency in the vessels from MetSyn, thereby, partially restored lymph flow. Thus, our data provide the first evidence that SERCA2a modulates the lymphatic pumping activity by regulating phasic contractile amplitude and frequency, but not the lymphatic tone.Diminished lymphatic contractile activity in the vessels from the MetSyn animal is associated with the decreased SERCA2a expression and impaired SERCA2 activity in lymphatic muscle.the risk for all causes of mortalities, including cardiovascular diseases 1,2 . Clinical studies have established the link between obesity and lymphatic dysfunction, which is associated with increased susceptibility for developing lymphedema 3-6 . Mice heterozygous for Prox1, a master lymphatic endothelial transcription factor, consistently develop adult onset obesity coupled with increased chyle accumulation in the thoracic cavity 7,8 . In addition, these mice exhibited higher leptin and insulin levels 8 , which are pathological determinant factors of insulin resistance suggesting a direct role of the lymphatic system in metabolic dysfunction. We have previously reported that a high-fructose-fed rat model of MetSyn presented a significant reduction in lymphatic pumping as a consequence of decreased phasic contractile frequency and impaired intrinsic lymphatic muscle force production 9,10 .These findings have been corroborated in the obese mouse models that diminished pressure-induced frequency in collecting lymphatic vessels 11 . We have also demonstrated that insulin resistance directly impaired cellular bioenergetics and decreased the relative levels of the regulatory molecule, myosin light chain 20 (MLC20) in lymphatic muscle cells (LMCs). However,...